The company seems to have trouble depositing dues in time:
Source: AR 2023
Dhanuka Agritech is a domestic mkt focussed formulator. The two categories in agrochemicals space that have been hit hard in last 1 odd yr are – makers to Active Ingidients ( due steep price falls due accelerated competition from China ) and Formulations exporters ( again due excessive aggression from China )
Dhanuka Agri – being absent from these categories, has been doing well
Ddev Plastiks Industries Ltd. (DPIL) stands as a notable leader in the polymer compounding industry, distinguished by its robust capacity of 239,000 MTPA. The company has carved out a significant market share by producing a diverse range of products such as polyethylene compounds, PVC compounds, and HFFR compounds. DPIL’s strategic approach, leveraging advanced R&D and maintaining a strong clientele base, including marquee names like KEI Industries and Havells India, positions it advantageously for sustained growth.
Despite an environment of high competitive intensity and raw material price volatility, DPIL has consistently showcased financial resilience. With an expanding product mix geared towards higher-margin offerings and a keen focus on operational efficiencies, DPIL has improved its EBITDA margins significantly. It maintains a lean operation with minimal long-term debt and showcases a commendable debt-to-equity ratio, which has been reducing over the years.
In terms of performance metrics, DPIL excels with a ROCE of 32.5% and an ROE of 23.5%. The company has also been proactive in shareholder returns, as evidenced by its consistent dividend policy with yields between 0.5% to 1%.
However, DPIL is not without its challenges. The company must navigate the risks associated with raw material supply dependency, competitive pressures from international giants, and currency rate fluctuations. Corporate governance also remains an area of scrutiny due to the company’s historical associations.
As DPIL continues to invest in high-margin and technologically advanced products, the potential for market re-rating becomes evident. The company’s stock, trading at a PE ratio significantly lower than the industry average, suggests a latent opportunity for value realization. With prudent financial management and strategic market positioning, DPIL appears poised for re-rating and continued prosperity.
Ddev Plastiks Industries Ltd. (DPIL) is a renowned entity within the polymer compounding sector, emerging as a powerhouse post its demerger from the Kkalpana Group. DPIL’s roots trace back to 1985, starting with a manufacturing unit for PVC compounds in Daman, India. Over the years, DPIL has substantially scaled up operations across various locations including West Bengal, Daman & Diu, Dadra & Nagar Haveli, and Noida, India.
DPIL’s core business revolves around producing a wide array of polymer compounds critical for multiple industrial applications. Their portfolio includes:
DPIL has optimized its manufacturing prowess to produce compounds that meet stringent international standards, ensuring a global appeal. Its facilities are strategically located to leverage logistical advantages and cater to a growing export market.
Innovation is the cornerstone of DPIL’s success. The company has invested in state-of-the-art R&D centers to pioneer the development of new compounds that offer enhanced performance while adhering to the evolving environmental regulations and industry standards.
Sustainability is woven into DPIL’s operational fabric. The company has instituted green initiatives, such as solar power adoption and water harvesting, to minimize its environmental footprint.
With a legacy spanning over three decades, DPIL is steered by a leadership team that brings a wealth of industry experience. The company’s governance structure is designed to uphold the highest standards of ethics and accountability.
Ddev Plastiks Industries Ltd. operates in the polymer compounding industry, which is a vital subset of the broader chemical manufacturing sector. Polymer compounds are essential materials used across a wide range of industries, including automotive, electronics, construction, and telecommunications. The demand for these products is closely tied to the growth of these end-use sectors.
The polymer compounding market is characterized by its diversity of applications and the continual evolution of material science. Innovation drives the development of new compounds that meet increasingly stringent industrial, environmental, and safety standards. In recent years, there has been a significant push towards sustainable and eco-friendly materials, such as HFFR compounds, driven by regulatory changes and shifting consumer preferences.
The industry is competitive, with several large multinational corporations dominating the high-end specialty segments of the market. These players, with their expansive product lines and economies of scale, pose a competitive challenge to smaller players like DPIL. However, DPIL’s focus on specialty and high-margin products has allowed it to carve out a niche and remain competitive.
DPIL has established itself as a leader in the domestic polymer compounding market, particularly in PE compounds for the wire and cable industry. The company’s significant market share is supported by its diverse product range, large-scale operations, and robust R&D capabilities. DPIL’s strategic focus on high-margin products and continuous product development has allowed it to maintain and expand its market position despite intense competition.
The industry’s growth is forecasted to remain strong, propelled by global trends such as urbanization, infrastructure development, and technological advancements in the automotive and electronics sectors. The Indian market, in particular, is expected to see substantial growth due to the government’s focus on infrastructure and the increasing demand for energy and telecommunications services.
A comprehensive examination of Ddev Plastiks Industries Ltd.’s financial health reveals a strong fiscal position and noteworthy growth metrics. Let’s break down the key financial elements:
DPIL has consistently displayed a robust revenue trajectory, with operating revenue reaching ₹2,509 Crore. This growth is propelled by the company’s strategic initiatives to expand its product portfolio and penetrate new markets. The improved profitability, with an operating margin that has increased from 5% in 2022 to 10% in the TTM period, is indicative of effective cost management and a higher proportion of value-added products.
The company’s return on capital employed (ROCE) and return on equity (ROE) are exemplary, with figures of 32.5% and 23.5%, respectively. These metrics are among the highest in the industry and illustrate DPIL’s efficient use of capital and shareholder equity to generate profits.
DPIL has demonstrated prudent debt management, significantly reducing its debt from ₹130 Crore in 2021 to ₹45 Crore in September 2023. The debt-to-equity ratio has followed this downward trend, dropping from 0.33% to an impressive 0.08%. This reduction underscores the company’s commitment to sustaining a strong balance sheet and reducing financial risk.
Cash flow efficiency is a hallmark of DPIL’s financial stability, with a CFO to PAT ratio of 139.42% and a CFO to EBITDA of 112%. These ratios reflect the company’s ability to generate cash from its operations, funding continued expansion and innovation without relying excessively on external financing.
DPIL’s dividend policy has been consistent, offering yields between 0.5% to 1%, demonstrating its commitment to providing shareholder returns. The steady dividend payouts, even amidst expansion and growth, speak to the company’s sound financial planning and confidence in its cash flow stability.
With robust internal accruals and controlled capital expenditure, DPIL maintains strong liquidity, enabling it to navigate market uncertainties effectively. The company’s capital allocation strategy balances between reinvesting in the business and rewarding shareholders, positioning it well for sustainable growth.
The financial analysis paints a picture of a company with disciplined fiscal management, impressive growth, and profitability metrics, and a solid foundation for continued success.
Evaluating Ddev Plastiks Industries Ltd.’s market performance and valuation involves analyzing how the stock is priced relative to its earnings, the returns it provides to shareholders, and its market capitalization.
As of the latest financial data, DPIL’s stock trades at a price-to-earnings (PE) ratio of 10.5, significantly lower than the industry average PE ratio of 30.4. This disparity suggests that the stock may be undervalued, presenting a potential opportunity for investors, especially when considering the company’s robust financials and growth prospects.
With a market cap of ₹1,773 crore, DPIL is considered a small-cap stock. This classification often comes with higher growth potential and possibly higher volatility. However, given the company’s strong fundamentals, it may also mean that DPIL is poised for re-rating as it gains more visibility among investors.
DPIL’s dividend policy reflects a yield ranging from 0.5% to 1%, underscoring the company’s commitment to consistently rewarding its shareholders. This yield, coupled with the company’s low PE ratio, contributes to making DPIL an attractive stock for value investors.
Historically, DPIL has traded at higher PE ratios. The current PE of 10.5 is at a historical low since the company’s listing, indicating that the stock might currently be trading at a discount to its intrinsic value based on earnings.
Recent insider trading data show that the promoter has increased their holding, purchasing 1,25,000 shares at ₹175, signaling confidence in the company’s future. This purchase price is slightly above the current trading price of ₹171, further indicating that the promoters believe the stock is undervalued.
With minimal institutional holding and no significant DII involvement, DPIL remains largely undiscovered by major institutional investors. This factor could be seen as a potential for upside if the company attracts institutional attention, leading to increased demand for the stock and possible re-rating.
When compared to its peers, DPIL’s financial metrics, particularly the growth in OPM from 5% in 2022 to 10% in TTM, stand out. This comparison underlines the company’s operational efficiency and effectiveness in capital utilization.
Ddev Plastiks Industries Ltd. (DPIL) has embarked on several strategic initiatives that align with its future outlook and core objectives of growth, innovation, and sustainability.
DPIL has significantly expanded its product portfolio by introducing high-margin products like XLPE compounds and Halogen Free Flame Retardant (HFFR) compounds. These products are in line with global trends towards more environmentally friendly and safety-compliant materials, particularly in the construction and automotive industries.
The company is aggressively targeting new markets to expand its global footprint. With 30% of its revenues already coming from exports, DPIL is focusing on enhancing its international market share, particularly in regions with growing infrastructure and construction sectors.
With the industry poised for growth due to increased demand in the wiring and cables sector, DPIL has plans to double its current capacity by FY25. This ambitious expansion is set to position DPIL as a leading ancillary player in the market, taking advantage of economies of scale and enhancing its competitive positioning.
DPIL has consistently placed a high value on R&D, investing in new technologies and processes to develop innovative products. This commitment is evident in its transition to more advanced, higher-margin products that have contributed to an EBITDA margin expansion from 6% to 11%.
Sustainability is a key component of DPIL’s long-term strategy. The company is investing in sustainable manufacturing practices, including waste reduction, energy efficiency, and resource conservation, to ensure its operations are environmentally responsible and align with global sustainability goals.
DPIL emphasizes strong corporate governance and ethical management practices. Following its demerger, the company has reinforced its commitment to transparent operations and adherence to regulatory standards, aiming to build investor confidence and long-term shareholder value.
DPIL’s outlook is robust, with the company set to benefit from several tailwinds in the industry. The focus on infrastructure development, the rise in the electric vehicles market, and the increasing demand for telecommunication services are expected to drive demand for DPIL’s products. With its strategic initiatives in place, DPIL is well-equipped to capitalize on these opportunities and sustain its growth momentum.
Despite the strong positioning and growth prospects of Ddev Plastiks Industries Ltd., there are inherent risks and challenges that the company faces which could potentially impact its business performance and investment outlook.
DPIL operates in a highly competitive industry with both domestic and international players. The company’s ability to maintain and increase its market share is contingent upon its competitive pricing, product innovation, and customer service. Intensified competition could lead to pricing pressures, margin contraction, and loss of market share.
The company’s profitability is susceptible to fluctuations in the prices of raw materials, such as LDPE/HDPE and PVC resin, which are crude oil derivatives. Volatility in these input costs could affect the company’s gross margins and overall financial performance. The management’s ability to hedge against these price fluctuations is crucial to maintaining stable margins.
DPIL is dependent on the steady supply of raw materials, a significant portion of which is imported. Any disruptions in the global supply chain could lead to production delays or increased costs, which could adversely affect the company’s operations.
As DPIL expands its product range and enters new markets, it must navigate an increasingly complex regulatory landscape. Compliance with environmental, health, and safety regulations across different jurisdictions can lead to additional costs or alter market dynamics.
Given the historical corporate governance issues related to the erstwhile parent company Kkalpana Industries, DPIL must continue to demonstrate its commitment to high governance standards to maintain investor confidence.
The polymer compounding industry is subject to rapid technological changes. Failure to keep pace with technological advancements could result in obsolescence of current product lines and impact DPIL’s competitive advantage.
With a considerable portion of revenue coming from exports, DPIL is exposed to currency exchange risks. Unfavorable currency movements could affect the company’s earnings in its reporting currency.
Global political tensions and policy changes in key markets can create an unpredictable business environment, affecting trade relations and market access for DPIL’s products.
SWOT Analysis
In conclusion, DPIL’s strategic positioning, coupled with its financial and operational strengths, presents it with ample opportunities for growth. However, it must navigate the industry’s competitive landscape and external risks diligently.
Ddev Plastiks Industries Ltd. (DPIL) stands out as a formidable player in the polymer compounding industry, backed by its strong financial performance, strategic market positioning, and commitment to innovation and sustainability. The company’s comprehensive product portfolio, catering to diverse industrial applications, and its focus on high-margin, specialized compounds position it well for continued growth amidst evolving market demands.
DPIL’s robust operational strategies and financial metrics underscore its potential as a compelling investment opportunity. The company’s proactive approach to expanding its product lines and entering new markets, coupled with its strategic initiatives aimed at capacity expansion and technological advancements, bodes well for its future prospects. Furthermore, DPIL’s efforts in maintaining high corporate governance standards and its strong emphasis on R&D and sustainability initiatives reinforce its commitment to long-term value creation.
However, potential investors must consider the inherent risks associated with raw material price volatility, competitive pressures, and regulatory changes. DPIL’s ability to effectively manage these risks will be crucial in sustaining its growth trajectory and market leadership position.
In summary, Ddev Plastiks Industries Ltd. presents a balanced profile of robust growth potential tempered by industry-specific challenges. With its strategic initiatives geared towards innovation, sustainability, and market expansion, DPIL is poised to navigate the complexities of the polymer compounding industry successfully. Investors willing to bear the industry risks could potentially reap the benefits of the company’s growth and re-rating prospects.
I can think of few reasons –
Private banks were trading at premium (P/B) and public sector banks were trading at discount and we can see now that PSBs have caught up and private banks P/B are fairly valued or undervalued. So, basically mean reversion has played out last few years.
Specifically, for Kotak, there was uncertainty around succession plan of Uday Kotak which kept price range bound.
Now that 2. is no longer an overhang and value funds like PPFAS adding Kotak their portfolio am hoping price will catch up with business value.
@kuldeep_agarwal As you know I am not an investment advisor. I just post my study.
Based on my study, I would like to mention two points.
What is your objective? What is your plan?
Momentum is not creating a PF per se, the created group keeps on changing, there will be churn, there will be many new entries and exits, not to mention losses.
This is an update to my previous post on pf changes. Due to breaching of one of the conditions by IREDA, the indices may have been changed again. This has affected smallcap250 index also. BSE has been removed and VGUARD has been reinstated. There are no 11 changes in the pf. Following this change,
Based on ranking:
Based on A → Z for easy tracking
Exit:
BSE, EIHOTEL, INFIBEAM, IRCON, KALYANKJIL, KAYNES, MCX, SUZLON, WELCORP exit.
COCHINSHIP and INTELLECT stay within the top 25 and hence remain.
Entry:
ACE, ANANDRATHI, CHALET, CHENNPETRO, HBLPOWER, INOXWIND, JAIBALAJI, SCHNEIDER, SIGNATURE make an entry.
DOMS with trading history of less than 6 months is not considered and POWERINDIA cannot enter as there is no vacancy.
Its been a very strange learning for me in some MNC controlled stocks. I am writing down random thoughts before evaluating the learning structurally.
I had invested, albiet in small percentage of approx 2% each in Agro tech foods and Johnson Hitachi AC. Why? Excellent parentage. Con Agra, Johnson controls and Hitachi all 3 are leaders in respective space. Relatively small caps in India, huge runway of growth and comparable valuations of sector.
What failed so far – Johnson Hitachi had been a great stock a decade prior to my entering. Business was riding positive waves. Then covid happened and it never recovered. Now probably I know why when someone posted a news in its thread that Johnson Controls want to sell their stake.
Same for Agro tech – Con agra was never serious about India business it seems and sold out and that too at significant discount.
How to catch such Promoter and management intent so that you do not hold future losers inspite of all good initial checks.
This is a case of gradual/silent loss of company vision from growing its parentage in country to lookout of exit. They do not even want to exit at peak of their business performance to get maximum exit returns. They are ok with whatever they get…thats the sad part…
Secondly, how to judge if new buyer will trigger a turnaround…if business is good…
referring my Max India/Healthcare’s frustrated exit only to see stock 15x with new promoters in next few years…
Disc. Invested biased. Not eligible for any advice. Post only for learning. Can be wrong in all my assessments.
I have compiled a list of MIDCAP150 MOMENTUM 50 INDEX stocks, with top-ranked stocks such as BSE, Prestige, and REC Ltd. I am considering creating a portfolio with midcap stocks. Would it be advisable to purchase them without any discretionary thinking?
Laurus Labs – Can be a great opportunity if the management is able to walk the talk wef Q4
Q3 FY 24 concall and results highlights –
Sales – 1195 vs 1545 cr ( down 23 pc )
EBITDA – 183 vs 404 cr ( down 55 pc, margins @ 15 vs 26 pc – steep decline. However, the gross margins were at 54 pc, up 1 pc YoY )
Net Profit – 23 vs 203 cr ( down 89 pc )
Segment wise revenues ( for 9M ending Dec 23 ) –
Formulations – 984 vs 747 cr, up 32 pc
Improved business in ARVs and arresting of price declines. Developed Mkt export formulations also picked up. Multiple product launches scheduled in US in next Qtr
APIs – 1800 vs 1895 cr, down 5 pc
Sales breakup of APIs –
ARVs – 61 pc, Onco APIs – 15 pc, Other APIs – 24 pc
New capacity addition in progress in the Onco APIs segment
CDMO – 686 vs 1939 cr, down 65 pc ( steep decline due large PO executed LY. Except for that, core business grew 30 pc )
Company has 50 plus projects in Phase – 1,2,3 + 10 molecules in commercial stages. Seeing good demand/enquiries for late stage NCE molecules
Animal Health contract has commenced commercial validation batches
800 cr capex in CDMO facilities is on track
Bio – 131 vs 80 cr, up 65 pc
Total – 3600 vs 4660 cr, down 23 pc
Management commentary –
Believe that capacity utilisations should improve wef Q4 and hence the company should be able to report significant margin recovery. The same was expected in Q3 but has been pushed back into Q4. Expect capacity utilisation to pick up in Q4 and EBITDA margins to cross 20 pc. The confidence for the same is coming from the order book lined up wef Q4. The same is expected to sustain in FY 25 as well
As the capacity utilisation improves, EBITDA margins should get a good bump up. Continued interest and CDMO enquiries is a very positive sign
The Animal health contract is a > 10 yr multi product contract for supply of 20+ APIs to Intervet GmbH, a subsidiary of Merk Animal Health Ltd
Company also has a > 10 yr agro-chem products CDMO contract at hand. Capex for the same is on. Commercial supplies may begin in H2 FY 25
Disc: hold a tracking position, will add more as and when better results start fructifying, biased, not SEBI registered
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!